Literature DB >> 28782479

Candida Infections and Human Defensins.

Vania Polesello1, Ludovica Segat2, Sergio Crovella2, Luisa Zupin3.   

Abstract

BACKGROUND: Candida species infections are an important worldwide health issue since they do not only affect immunocompromised patients but also healthy individuals. The host developed different mechanisms of protection against Candida infections; specifically the immune system and the innate immune response are the first line of defence. Defensis are a group of antimicrobial peptides, components of the innate immunity, produced at mucosal level and known to be active against bacteria, virus but also fungi.
OBJECTIVES: The aim of the current work was to review all previous studies in literature that analysed defensins in the context of Candida spp. infections, in order to investigate and clarify the exact mechanisms of defensins anti-fungal action.
METHODS: Several studies were identified from 1985 to 2017 (9 works form years 1985 to 1999, 44 works ranging from 2000 to 2009 and 35 from 2010 to 2017) searched in two electronic databases (PubMed and Google Scholar). The main key words used for the research were "Candida", "Defensins"," Innate immune system","fungi". RESULTS AND
CONCLUSION: The findings of the reviewed studies highlight the pivotal role of defensins antimicrobial peptides in the immune response against Candida infections, since they are able to discriminate host cell from fungi: defensins are able to recognize the pathogens cell wall (different in composition from the human ones), and to disrupt it through membrane permeabilization. However, further research is needed to explain completely defensins' mechanisms of action to fight C. albicans (and other Candida spp.) infections, being the information fragmentary and only in part elucidated. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Candida; Defensins; fungi; infection; innate immunity; mucosa

Mesh:

Substances:

Year:  2017        PMID: 28782479     DOI: 10.2174/0929866524666170807125245

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  7 in total

Review 1.  Amyloidogenic Peptides: New Class of Antimicrobial Peptides with the Novel Mechanism of Activity.

Authors:  Oxana V Galzitskaya; Stanislav R Kurpe; Alexander V Panfilov; Anna V Glyakina; Sergei Y Grishin; Alexey P Kochetov; Evgeniya I Deryusheva; Andrey V Machulin; Sergey V Kravchenko; Pavel A Domnin; Alexey K Surin; Viacheslav N Azev; Svetlana A Ermolaeva
Journal:  Int J Mol Sci       Date:  2022-05-13       Impact factor: 6.208

2.  Boric Acid Solution Inhibits Candida albicans Infections in Mouse Skin via the IL-23/Th17 Axis.

Authors:  Zhao Liu; Qing Liu; Yanyan Xu; Zhao Han; Ling Zhang; Xiaojing Li
Journal:  Front Microbiol       Date:  2022-06-16       Impact factor: 6.064

3.  Nonphotodynamic Roles of Methylene Blue: Display of Distinct Antimycobacterial and Anticandidal Mode of Actions.

Authors:  Rahul Pal; Moiz A Ansari; Venkata Saibabu; Shrayanee Das; Zeeshan Fatima; Saif Hameed
Journal:  J Pathog       Date:  2018-01-31

4.  iDEF-PseRAAC: Identifying the Defensin Peptide by Using Reduced Amino Acid Composition Descriptor.

Authors:  Yongchun Zuo; Yu Chang; Shenghui Huang; Lei Zheng; Lei Yang; Guifang Cao
Journal:  Evol Bioinform Online       Date:  2019-07-31       Impact factor: 1.625

Review 5.  Innate Inspiration: Antifungal Peptides and Other Immunotherapeutics From the Host Immune Response.

Authors:  Derry K Mercer; Deborah A O'Neil
Journal:  Front Immunol       Date:  2020-09-17       Impact factor: 7.561

Review 6.  Bioactive Antimicrobial Peptides: A New Weapon to Counteract Zoonosis.

Authors:  Luisa Zupin; Carlos André Dos Santos-Silva; Aya R Hamad Al Mughrbi; Livia Maria Batista Vilela; Ana Maria Benko-Iseppon; Sergio Crovella
Journal:  Microorganisms       Date:  2022-08-07

Review 7.  Oral Cavity and Candida albicans: Colonisation to the Development of Infection.

Authors:  Mrudula Patel
Journal:  Pathogens       Date:  2022-03-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.